Invasive micropapillary carcinoma of the breast has a better long‐term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case–control analysis
Open Access
- 26 October 2017
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 6 (12), 2775-2786
- https://doi.org/10.1002/cam4.1227
Abstract
There are controversies in the comparison of overall survival between invasive micropapillary carcinoma of the breast (IMPC) and invasive ductal carcinoma (IDC). The objective of this study was to compare the long-term survival outcome between non-metastatic IMPC and IDC. The Surveillance, Epidemiology, and End Results database was searched to identify women with non-metastatic IMPC and IDC diagnosed between 2001 and 2013. Comparisons of patient and tumor characteristics were performed using Pearson's chi-square. The propensity score matching method was applied with each IMPC matched to one IDC. Breast cancer-specific survival (BCSS) and overall survival (OS) were estimated using the Kaplan–Meier product limit method and compared across groups using the log-rank statistic. Multivariate analysis was performed through Cox models. IMPC was presented with aggressive clinical presentations such as larger tumor, more positive lymph nodes, and more advanced stage compared with IDC. A higher rate of estrogen receptor (ER)/progesterone receptor (PR) positivity was also observed in IMPC. With a median follow-up of 64 months, IMPC had a better BCSS (P = 0.031) and OS (P = 0.012) compared with IDC. In a case–control analysis IMPC was still an independent favorable prognostic factor for BCSS (HR = 0.410, P < 0.001, 95% CI: 0.293–0.572) and OS (HR = 0.497, P < 0.001, 95% CI: 0.387–0.637). In subgroup analysis, IMPC always showed a better survival outcome compared with IDC except in AJCC stage I and histologic grade I disease. IMPC has a better long-term survival outcome compared with IDC in spite of its highly aggressive clinical presentation.Keywords
This publication has 29 references indexed in Scilit:
- Characteristic Morphology of Invasive Micropapillary Carcinoma of the Breast: An Immunohistochemical AnalysisJapanese Journal of Clinical Oncology, 2010
- Refinement of breast cancer classification by molecular characterization of histological special typesThe Journal of Pathology, 2008
- Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breastThe Journal of Pathology, 2008
- Breast Carcinoma With Micropapillary Features: Clinicopathologic Study and Long-Term Follow-Up of 100 CasesInternational Journal of Surgical Pathology, 2008
- Carcinomas with Micropapillary MorphologyAdvances in Anatomic Pathology, 2004
- Invasive Micropapillary Carcinoma of the BreastAmerican Journal of Clinical Pathology, 2004
- Invasive Micropapillary Carcinoma of the Breast : Clinicopathologic Study of 62 Cases of a Poorly Recognized Variant With Highly Aggressive BehaviorAmerican Journal of Clinical Pathology, 2004
- Does local recurrence affect the rate of distant metastases and survival in patients with early‐stage breast carcinoma treated with breast‐conserving therapy?Cancer, 2003
- Clinicopathologic Analysis of Invasive Micropapillary Differentiation in Breast CarcinomaLaboratory Investigation, 2001
- Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54Pathology - Research and Practice, 2000